We present a novel approach called ChemMaps for visualizing chemical space based on the similarity matrix of compound datasets generated with molecular fingerprints' similarity. The method uses a 'satellites' approach, where satellites are, in principle, molecules whose similarity to the rest of the molecules in the database provides sufficient information for generating a visualization of the chemical space. Such an approach could help make chemical space visualizations more efficient. We hereby describe a proof-of-principle application of the method to various databases that have different diversity measures. Unsurprisingly, we found the method works better with databases that have low 2D diversity. 3D diversity played a secondary role, although it becomes increasingly relevant as 2D diversity increases. For less diverse datasets, taking as few as 25% satellites seems to be sufficient for a fair depiction of the chemical space. We propose to iteratively increase the satellites number by a factor of 5% relative to the whole database, and stop when the new and the prior chemical space correlate highly. This Research Note warrants the full application of this method for several datasets.
Introduction
Visual representation of chemical space has multiple implications in drug discovery for virtual screening, library design and comparison of compound collections, among others 1 . Amongst the multiple methods to explore chemical space, principal component analysis (PCA) of pairwise similarity matrices computed with structural fingerprints has been used to analyze compound datasets 2, 3 . A drawback of this approach is that it becomes impractical for large libraries due to the large dimension of the similarity matrix 4 . Other approaches use molecular representations different from structural fingerprints, such as physicochemical properties or complexity descriptors, or methods different from PCA, such as multidimensional-scaling and neural networks 5, 6 .
In representation of the chemical space based on PCA there have been "chemical satellite" approaches, such as ChemGPS, which select satellites molecules that might not be included in the database to visualize, but have extreme features that place them as outliers, with the intention to reach as much of the chemical space as possible [7] [8] [9] . Although we concur with the fact that not all compounds in a compound data set should be necessary to generate a meaningful chemical space, there are still obvious limitations of using a fixed set of satellites to which the user is blinded.
We therefore suggest the hybrid approach, ChemMaps, in which a portion of the database to be represented is used as satellite, thereby decreasing the computational effort required to compute the similarity matrix without losing adaptability of the method to any particular database. Since it is expected that more diverse sets would require more satellites, a second goal of this study was to qualitatively explore the relationship between the internal diversity of compound datasets and the fraction of compounds required as satellites, in order to generate a good approximation of the chemical space. Table 1 summarizes the six compound data sets considered in this study. Note that small median similarity values imply higher diversity. The datasets were selected from a large scale study of profiling epigenetic datasets (unpublished study, Naveja JJ and Medina-Franco JL) with relevance in epigenetic-drug discovery. We also included DrugBank as a control diverse dataset 10 . Briefly, we selected focused libraries of inhibitors of DNMT1 (a DNAmethyltransferase; library diverse 2D and 3D), L3MBTL3 (a histone methylation reader; diverse 3D and less diverse 2D), SMARCA2 (a chromatin remodeller; diverse 2D, less diverse 3D), and CREBBP (a histone acetyltransferase; less diverse both 2D and 3D). Datasets were selected based on their different internal diversity (as measured with Tanimoto index/MACCS keys for 2D measurements and Tanimoto combo/OMEGA-ROCS for 3D; see Figure S1 in Supplementary File 1). Data sets in this work have approximately the same number of compounds except for HDAC1 and DrugBank, which were selected to benchmark the method in larger databases (Table 2) . We evaluated 2D diversity using the median of Tanimoto/MACCS similarity measures in KNIME version 3.3.2, and 3D diversity using the median of Combo Score from the ROCS, version 3.2.2 and OMEGA, version 2.5.1, OpenEye software [11] [12] [13] [14] .
Methods
To assess the hypothesis of this work we performed two main approaches A): Backwards approach: start with computing the full similarity matrix of each data set and remove compounds systematically; and B) Forward approach: start adding compounds to the similarity matrix until finding the reduced number of 
Backwards approach
The following steps were implemented in an automated workflow in KNIME, version 3.3.2 15 :
1. For each compound in the dataset with N compounds, generate the N X N similarity matrix using Tanimoto/extended connectivity fingerprints radius 4 (ECFP4) generated with CDK KNIME nodes.
2. Perform PCA of the similarity matrix generated in step 1 and selected the first 2 or 3 principal components (PCs).
3. Compute all pair-wise Euclidean distances based on the scores of the 2 or 3 PCs generated in step 2. The set of distances are later used as reference or 'gold standard'.
4. Repeat steps 1 to 3 with one compound as satellite, generating an N X 1 similarity matrix. The first compound was selected randomly. In this case, for example, it is only possible to calculate one PC, but as the number of satellites increases, we can again compute 2 or 3 PCs.
5. Calculate the correlation among the pairwise distances generated in step 2 obtained using the whole matrix (e.g., gold standard) and those obtained in step 4.
6. Iterate over steps 4 and 5 increasing the number of satellites one by one until N -1 satellites are reached. To select the second, third, etc. compounds, two approaches were followed: select compounds at random and select compounds with the largest diversity to the previously selected (i.e., Max-Min approach).
7. Estimate the proportion of satellite compounds required to preserve a 'high' (of at least 0.9) correlation.
8. The prior steps were repeated five times for each dataset in order to capture the stability of the method.
Forward approach
The former approach is useful only for validation purposes of the methodology as a proof-of-principle. However, the obvious objective of a satellite-approach is to avoid the calculation of the complete similarity matrix e.g., step 1 in backwards approach. To this end, we developed a satellite-adding or forward approach, in contrast with the formerly introduced backwards approach. We started with 25% of the database as satellites and for each iteration we added 5% until the correlation of the pairwise Euclidean distances remains high (at least 0.9). 
Results

Backwards approach
In this pilot study, we assessed a few variables to tune up the method, such as the number of PCs used (2 or 3) and the selection of satellites at random or by diversity. We found that selection at random is more stable, above all in less diverse datasets ( Figure 1 and Figure 2 ; Figure S2 and Figure S3 ). Likewise, selecting 2 PCs the performance is slightly better and more stable (compare Figure 1 and Figure 2 against Figure S2 and Figure S3 ).
Therefore, from this point onwards we will focus on the results of the at random satellites selection and using 2 PCs (Figure 2 ). From the four datasets, we conclude that for datasets with lower 2D diversity (CREBBP and L3MBTL3, see Table 1 ), around 25% of satellite compounds are enough to obtain a high correlation (≥ 0.9) with the gold standard (e.g., PCA on the whole matrix). Whereas for 2D-diverse datasets i.e., DNMT1 and SMARCA2, up to 75% of the compounds could be needed to ensure a high correlation. Nonetheless, even for these datasets, using 25% of the compounds as satellites the correlation with the gold standard is already between 0.6 and 0.8; using 50% of the compounds as satellites the correlation is between 0.7 and 0.9. Hence, the higher the diversity of a dataset (especially 2D), the higher the number of satellites required.
Forward approach
Evidently, a useful method for reducing computing time and disk usage space should not use the PCA on the whole similarity matrix to determine an adequate number of satellites for each dataset. With that in mind, we decided to design a method that starts with a given percentage of the database as satellites, and then keeps adding a proportion of them until the correlation between the former and the updated data is of at least 0.9. In Figure 3 we depict this approach on the same databases in Table 1 for step sizes of 5% and starting from zero. Similarly as what we saw in the backwards method, around 5 steps (25% of the database) are usually necessary to reach a stable, high correlation between steps. Figure S4 shows that for step sizes of 10% there is no further improvement. Therefore we suggest that the method should, for default, start with 25% of compounds as satellites and then keep adding 5% until a correlation between steps of at least 0.9 is reached.
Application
In this pilot study we applied the method to visualize the chemical space of two larger datasets (HDAC1 and DrugBank with 3,257 and 1,900 compounds, respectively, Table 1 ). As shown in Table 2 , a significant reduction in time performance was achieved as compared to the gold standard, and the correlation between the gold standard and the satellites approach was in both cases higher than 0.9. Figure 4 depicts the chemical spaces generated in both instances. Although the orientation of the map changed for HDAC1, the shape and distances remain quite similar, which is the main objective. This preliminary work supports the hypothesis that a reduced number of compounds is sufficient to generate a visual representation of the chemical space (based on PCA of the similarity matrix) that is quite similar to the chemical space of the PCA of the full similarity matrix. 
Conclusion and future directions
This proof-of-concept study suggests that using the adaptive satellite compounds ChemMaps is a plausible approach to generate a reliable visual representation of the chemical space based on PCA of similarity matrices. The approach works better for relatively less-diverse datasets, although it seems to remain robust when applied to more diverse datasets. For datasets with small diversity, fewer satellites seem to be enough to produce a representative visual representation of the chemical space. The higher relevance of 2D diversity over 3D in this study could be importantly related to the fact that the chemical space depiction is based on 2D fingerprints. Therefore, the performance of the methods depicting the chemical space based on 3D fingerprints could also be assessed.
A major next step is to conduct a full benchmark study to assess the general applicability of the approach proposed herein, and also in larger databases, in which we anticipate this method would be even more useful. A second step is to propose a metric that determines the number of compounds required as satellites for PCA representation of the chemical space based on similarity matrices. 1.
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5. In general, the approach involves selection of satellite compounds from the database, computing the similarities of all compounds in the database to these satellites, and finally projection of the resulting similarity matrix using principal component analysis. J. Jesús Naveja further report various et al methods for selecting satellite compounds (backward or forward selection approach; selection at random or selection by diversity check) and show how the number of selected satellite compounds influence the quality of projection.
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Comments:
The authors are completely hiding the fact that similarity mapping is quite well-known and absolutely not new, the authors should read and cite Awale et al., J. Chem. Inf. Model., 2015, 55 (8), pp 1509-1516 and the detailed discussion of literature precedents on similarity mapping presented therein.
The authors compare their satellites to the satellite compounds used by T. Oprea in his 2001 approach to mapping chemical space. Obviously either they did not read Oprea's paper or they misunderstood it: Oprea's satellites are artificial molecules with extreme properties such as to orient the PCA projection and stretch its dimensions in reproducible directions. However the projection is simply PCA, and does not involve similarity mapping. In similarity mapping the satellites are molecules from within the database to which similarities are calculated.
In the abstract, author mentioned that "3D diversity played a secondary role, although it becomes increasingly relevant as 2D diversity increases". However, I didn't found the relevant explanation in main text supporting this statement. In case of forward selection approach: "..With that in mind, we decided to design a method that starts with a given percentage of the database as satellites, and then keeps adding a proportion of them until the correlation between the former and the updated data is of at least 0.9. " The correlation between projections obtained from the current set of satellites and projections obtained from former set of satellites might well be high, but still the correlation to the projection obtained 5.
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correlation between projections obtained from the current set of satellites and projections obtained from former set of satellites might well be high, but still the correlation to the projection obtained from the complete similarity matrix is low. How one can assure the quality of projection in this case?
For all plots axis labels are too small to read. 
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understandable, the paper lacks several technical details without which it is not complete. In particular:
The concept of 'chemical satellites' is discussed in a rather concise manner, a bit more details may be added and the seminal paper by Oprea & Gottfries [1] needs to be cited. The approach suggested here is rather different from the Oprea's one, because satellites are defined there as intentional outliers, whereas in the current work they are just extracted from the mapped dataset. This difference should be stated in a clearer way.
Dataset processing routine is not presented. Although the suggested technique would work on totally random datasets (by the way, addition of such a dataset to the list of examples would be beneficial and illustrative), standardization of structures should be performed for consistency and for more informative application of similarity measures. Targeted datasets in the supplement look standardized, but DrugBank contains metal ions, unconnected molecules, and macromolecules, all of which may significantly distort the comparison. For HDAC1 inhibitors the procedure to obtain this dataset from ChEMBL should be provided, because simple target keyword search for 'hdac1' gives 9 different datasets.
Diversity of datasets may be additionally illustrated by any of currently available visualization methods. A method that clearly shows compound clustering or diversity of the dataset would be preferred.
Visual comparison of figures is not sufficient to make conclusions about preference of random selection over diversity-based (Figures 1, 2, S2, S3 ). Differences are visible, but their importance and significance are not obvious (maybe just for me), so use of a quantitative measure would be highly appreciated. Random selection shows sometimes lower stability of the backwards analysis (larger difference between the iterations), and this observation could be discussed.
Some analysis of the technique applicability domain would significantly improve the conclusions of the paper. One parameter that deserves attention is dataset diversity threshold above which the technique becomes unstable or less useful. Will it work good for totally random or intentionally diverse compounds or for datasets with two or three large congeneric series? A slightly more thorough characterization of example datasets would be useful to deal with this question. 
